NZM2:ETR
Novozymes
51,12 €
0,00%
(0,00) 1 D
29. apr., 17:35:37 GMT+2 · EUR
search
Alle symboler
1 D
5 D
1 M
6 M
I år
1 Å
5 Å
MAKS
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for NZM2 …
Markedsverdi
165,66 mrd.
Snittvolum
179,00
Volum
0,00
52 u høy
57,24 €
52 u lav
46,74 €
Antall ansatte
11k
Nyhetssaker
Fra kilder på nettet
Simply Wall Street
·
for 10 minutter siden
How Raiffeisen Corporate Lending Win and APAC Leadership Move Will Impact nCino (NCNO) Investors
Benzinga
·
for 35 minutter siden
Jim Chanos Warns AI Capex To Boost S&P 500 EPS Estimates - Meta Platforms (NASDAQ:META)
24/7 Wall St.
·
for 1 time siden
Should You Dump Bitcoin for Stocks After the S&P 500 Hit a New Record on Apple's $100 Billion Buyback?
Seeking Alpha
·
for 2 timer siden
Stocks ignore oil shock for now, but markets face growing crosswinds
Profil
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
Om Novozymes
Administrerende direktørEster Baiget
Ansatte11,1k
Grunnlagt2000
Hovedkontor-
SektorSpeciality chemicals
Nettstednovonesis.com
AI-innhold kan inneholde feil. Finn ut mer